Skip to content

Effect of Structured Training Program in Diabetic Patients

Effect of Structured Training Program on Functional Abilities in Patients With Diabetic Neuropathy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06262074
Enrollment
60
Registered
2024-02-15
Start date
2024-02-08
Completion date
2024-03-31
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Peripheral Neuropathy

Brief summary

Diabetic neuropathy, a challenging condition resulting from poorly managed type-1 or type-2 diabetes mellitus, often proves resistant to conventional medications when it comes to alleviating the associated symptoms. In such cases, implementing a well-organized exercise regimen has proven beneficial in mitigating diverse symptoms associated with the condition and enhancing the overall quality of life for affected individuals.

Detailed description

The goal of this type of interventional study is to assess the effect a well-defined exercise program for individuals with DPN, despite the existence of various individualized exercise programs designed for DPN patients. The main questions this study aims to answer is: What is the effect of a 4-weeks structured training program as an adjunct to general lower limb exercise in patients with DPN on pain, sensory symptoms, balance, vibration sense and Quality of life? Group 1: Patients in group 1 will receive a structured exercise program. Group 2: Patients in group 2 will receive a non-structured exercise program. This group will allow us to compare the effects of a structured and a non-structured exercise program.

Interventions

30 minutes of structured exercise programs

OTHERNon structured exercise program

Non structured exercises

Sponsors

Maharishi Markendeswar University (Deemed to be University)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Diabetes mellitus with moderate to severe DPN * Subjects of both gender * Age from 40 to 70 years * Independent walking * MNSI score more than 2 out of 13

Exclusion criteria

* Presence of an active planter ulcer * History of surgery during intervention period * Neurological diseases other than DPN

Design outcomes

Primary

MeasureTime frameDescription
Michigan neuropathy screening instrument (MNSI)The measurement will be taken during the baseline assessment and again after the completion of treatment.The scale consists of two parts: the first part involves a patient history assessment, while the second part focuses on physical examination. This scale is considered both reliable and practical for evaluating the severity of neuropathy. If the patient's score increases, it indicates a higher severity of the disease, whereas if the score decreases, it suggests a lower severity.
BiothesiometerThe measurement will be taken during the baseline assessment and again after the completion of treatment.This objective measure is utilized to assess the vibratory pressure threshold in affected areas. It possesses the capability to detect various frequencies for vibratory pressure threshold assessment. It is regarded as a practical tool for evaluating both superficial and vibratory sensations. If there is an increased perception of frequency, it indicates that the vibratory pressure threshold is more severely affected.
NeuroQoLThe measurement will be taken during the baseline assessment and again after the completion of treatment.The Neuropathy-and Foot-Ulcer Specific Quality of Life Instrument is designed as a Likert scale and serves as a reliable method for assessing quality of life related to neuropathy. If the scoring indicates a higher value, it suggests that the disease is more severe.

Secondary

MeasureTime frameDescription
NPRSThe measurement will be taken during the baseline assessment and again after the completion of treatment.The Numeric Pain Rating Scale, ranging from 0 to 10, is employed as a subjective assessment tool to measure an individual's pain perception. In general, higher scores on the scale indicate a greater severity of pain linked to the disease.

Countries

India

Contacts

Primary ContactSubhasish Chatterjee, PhD
subhasishphysio@mmumullana.org8708660994
Backup ContactKhushboo Kumari, BPT (MPT)
physio.khushboo11@gmail.com08718089830

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026